Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium antagonists--clinical considerations

L M Prisant1

  • 1Hypertension Unit, Medical College of Georgia, Augusta, USA.

Ethnicity & Disease
|May 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality in patients with microvascular disease.

Journal of clinical hypertension (Greenwich, Conn.)·2004
Same author

Coarctation of the aorta: a secondary cause of hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2004
Same author

Arterial elasticity among normotensive subjects and treated and untreated hypertensive subjects.

Blood pressure monitoring·2002
Same author

Verapamil revisited: a transition in novel drug delivery systems and outcomes.

Heart disease (Hagerstown, Md.)·2002
Same author

Hypertension images: electrocardiographic left ventricular hypertrophy.

Journal of clinical hypertension (Greenwich, Conn.)·2001
Same author

Hypertension and chronotherapy: shifting the treatment paradigm.

American journal of hypertension·2001

Calcium antagonists effectively treat hypertension and angina but should be avoided in acute heart conditions. Careful consideration of drug interactions is crucial, with ongoing trials comparing them to other cardiovascular therapies.

Area of Science:

  • Cardiovascular Pharmacology
  • Clinical Cardiology

Background:

  • Calcium antagonists are established treatments for hypertension, angina, and arrhythmias.
  • Emerging evidence supports their role in reducing nonfatal stroke rates.

Purpose of the Study:

  • To review the therapeutic applications of calcium antagonists.
  • To highlight contraindications and precautions for their use.
  • To contextualize their role in ongoing cardiovascular drug trials.

Main Methods:

  • Literature review of calcium antagonist efficacy and safety.
  • Analysis of contraindications in acute cardiovascular conditions.
  • Discussion of drug-drug interactions with non-dihydropyridines.
  • Overview of comparative trials with other cardiovascular agents.

Related Experiment Videos

Main Results:

  • Calcium antagonists are beneficial for hypertension, stable angina, vasospastic angina, and supraventricular arrhythmias.
  • They have demonstrated efficacy in decreasing nonfatal stroke rates.
  • Short-acting formulations are contraindicated in hypertensive emergencies, unstable angina, and acute myocardial infarction.
  • Non-dihydropyridines require caution due to potential drug-drug interactions.
  • Calcium antagonists are not recommended as primary therapy for systolic heart failure.

Conclusions:

  • Calcium antagonists offer significant benefits in managing various cardiovascular conditions.
  • Appropriate patient selection and awareness of contraindications are essential for safe and effective use.
  • Ongoing research will further define the comparative role of calcium antagonists alongside newer cardiovascular medications.